Short description
diaDexus is a biotechnology company focused on the development and commercialization of diagnostic products with high clinical value.
Description
diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value.
The company's lead product, the PLAC Test, measures Lp-PLA2 (lipoprotein-associated phospholipase A2) a vascular-specific inflammatory enzyme implicated in the formation of rupture-prone plaque. It is plaque rupture and thrombosis, not stenosis, that cause the majority of cardiovascular events. The PLAC Test is the only blood test cleared by the FDA as an aid in assessing risk for coronary heart disease, and ischemic stroke associated with atherosclerosis.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
South San Francisco, California, United States, North America
Founded on
January 1, 1997
Closed on
August 1, 2016
Exited on
June 1, 1999
Went public on
June 1, 1999
Stock symbol
DDXS
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$1230 - 4560
Sign in for full access
Investors
Noaccess, Absolutely Noaccess, Nopepepe, Noaccess, Noway Youcantaccess, Noway Youcantaccess, Nopepepe, Absolutely Noaccess, Cannot Access
Sign in for full access